oncology patient-centricity-integration-enhancing-cancer-outcomes 
European Pharmaceutical Review
MARCH 4, 2024
Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Introducing virus-like particles (VLPs) is an alternative strategy for enhancing the efficacy of gene therapy applications.
Proxsys Rx
APRIL 4, 2024
Some disease states are projected to experience even higher increases in patient volume. The medications and expert services that specialty pharmacies provide expedite patient access to care, ensure appropriate medication use, and achieve superior clinical and cost-effective outcomes. Bottom Line: Better Outcomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 30, 2021
Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.
Proxsys Rx
AUGUST 22, 2023
Some disease states are projected to experience even higher increases in patient volume. The medications and expert services that specialty pharmacies provide expedite patient access to care, ensure appropriate medication use, and achieve superior clinical and cost-effective outcomes. Bottom Line: Better Outcomes.
Proxsys Rx
DECEMBER 22, 2023
Some disease states are projected to experience even higher increases in patient volume. The medications and expert services that specialty pharmacies provide expedite patient access to care, ensure appropriate medication use, and achieve superior clinical and cost-effective outcomes. Bottom Line: Better Outcomes.
Expert insights. Personalized for you.
92 
Let's personalize your content